| Předmět: |
|
| Zdroj: |
Diabetes; Jun 2014 Supplement, pA263-A292, 30p, 1 Color Photograph, 6 Black and White Photographs, 29 Charts, 4 Graphs, 1 Map |
| Abstrakt: |
The article presents abstracts of studies related to oral agents for the treatment of diabetes, which include research on the effects of sitagliptin and exenatide on plasma concentrations of betatrophin, a peptide secreted by hepatocytes that plays a role in ß-cell function and proliferation, in patients with type 2 diabetes, and evaluation of the glycemic efficacy of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
